Chronic Disease Surveillance in US Pacific Islands
Author Information
Author(s): Hosey Gwen MS, ARNP, CDE, Ichiho Henry MD, MPH, Satterfield Dawn PhD, RN, Dankwa-Mullan Irene MD, MPH, Kuartei Stevenson MD, Rhee Kyu MD, MPP, Belyeu-Camacho Tayna, deBrum Ione, Demei Yorah, Lippwe Kipier, Solidum Luces Patrick, Roby Faiese MD
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
The study aims to assess the quality of existing chronic disease data sources and identify jurisdictional capacity for chronic disease surveillance in the US Associated Pacific Islands.
Conclusion
The study found that while USAPI data sources are generally aligned with chronic disease surveillance indicators, there is a need for improved data collection and integration.
Supporting Evidence
- USAPI jurisdictions are using both population-based and institution-based data sources for chronic disease surveillance.
- Data sources are aligned with widely accepted indicators for chronic disease surveillance.
- Jurisdictions reported participation in standardized population-based surveys.
- Challenges exist with obtaining representative samples for surveys.
- Financial resources and organizational capacity are limited for some jurisdictions.
Takeaway
This study looks at how well the US Pacific Islands track chronic diseases and suggests ways to do it better.
Methodology
The study involved a chronic disease data source inventory, literature review, and assessment of data quality using WHO's Health Metric Network Framework.
Potential Biases
Potential biases include underreported vital statistics and systematic biases in diagnosis due to limited medical support.
Limitations
The study did not assess biases within population-based data sources and noted challenges with data quality and timeliness.
Participant Demographics
The jurisdictions include American Samoa, Guam, CNMI, FSM, Palau, and RMI, with diverse populations across 104 inhabited islands.
Want to read the original?
Access the complete publication on the publisher's website